Regeneron Pharmaceuticals, Inc. (REGN)

783.71 -1.46 (-0.19%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Regeneron Pharmaceuticals Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade